These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 9210716

  • 1. Radical chemoradiotherapy for elderly patients with bladder carcinoma invading muscle.
    Arias F, Dueñas M, Martínez E, Domínguez MA, Illarramendi JJ, Villafranca E, Tejedor M, Molina F, Meiriño R, Valerdi JJ.
    Cancer; 1997 Jul 01; 80(1):115-20. PubMed ID: 9210716
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.
    Urology; 2004 Sep 01; 64(3):488-93. PubMed ID: 15351577
    [Abstract] [Full Text] [Related]

  • 4. Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study.
    Vikram B, Chadha M, Malamud SC, Hecht H, Grabstald H.
    Cancer; 1998 Mar 01; 82(5):918-22. PubMed ID: 9486582
    [Abstract] [Full Text] [Related]

  • 5. Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.
    Maarouf AM, Khalil S, Salem EA, ElAdl M, Nawar N, Zaiton F.
    BJU Int; 2011 May 01; 107(10):1605-10. PubMed ID: 20825396
    [Abstract] [Full Text] [Related]

  • 6. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
    Zapatero A, Pinar B, Arellano R, López M, Marín A, Jiménez U, Pérez Torrubia A.
    Arch Esp Urol; 1997 Jun 01; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
    [Abstract] [Full Text] [Related]

  • 7. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
    Hata M, Miyanaga N, Tokuuye K, Saida Y, Ohara K, Sugahara S, Kagei K, Igaki H, Hashimoto T, Hattori K, Shimazui T, Akaza H, Akine Y.
    Int J Radiat Oncol Biol Phys; 2006 Apr 01; 64(5):1371-9. PubMed ID: 16580495
    [Abstract] [Full Text] [Related]

  • 8. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
    Danesi DT, Arcangeli G, Cruciani E, Altavista P, Mecozzi A, Saracino B, Orefici F.
    Cancer; 2004 Dec 01; 101(11):2540-8. PubMed ID: 15481058
    [Abstract] [Full Text] [Related]

  • 9. Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer.
    Lin CC, Hsu CH, Cheng JC, Huang CY, Tsai YC, Hsu FM, Huang KH, Cheng AL, Pu YS.
    Int J Radiat Oncol Biol Phys; 2009 Oct 01; 75(2):442-8. PubMed ID: 19307067
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chemoradiotherapy for muscle invading bladder carcinoma. Final report of a single institutional organ-sparing program.
    Arias F, Domínguez MA, Martínez E, Illarramendi JJ, Miquelez S, Pascual I, Marcos M.
    Int J Radiat Oncol Biol Phys; 2000 May 01; 47(2):373-8. PubMed ID: 10802362
    [Abstract] [Full Text] [Related]

  • 13. [Polychemotherapy in advanced bladder cancer. Practicality and clinical results].
    Klän R, Knispel H, Huland H.
    Urologe A; 1992 Jul 01; 31(4):247-50. PubMed ID: 1514213
    [Abstract] [Full Text] [Related]

  • 14. Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy.
    Chauvet B, Brewer Y, Félix-Faure C, Davin JL, Choquenet C, Reboul F.
    J Urol; 1996 Oct 01; 156(4):1258-62. PubMed ID: 8808849
    [Abstract] [Full Text] [Related]

  • 15. Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer.
    Bex A, Nieuwenhuijzen JA, Kerst M, Pos F, van Boven H, Meinhardt W, Horenblas S.
    Urology; 2005 Feb 01; 65(2):295-9. PubMed ID: 15708041
    [Abstract] [Full Text] [Related]

  • 16. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
    Tsukamoto S, Ishikawa S, Tsutsumi M, Nakajima K, Sugahara S.
    Scand J Urol Nephrol; 2002 Feb 01; 36(5):339-43. PubMed ID: 12487737
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of recombinant human granulocyte colony stimulating factor on dose intensity and toxicity of three cycles of methotrexate, vinblastine, doxorubicin and cisplatin in patients with previously untreated urothelial bladder carcinoma.
    Viens P, Gravis G, Bladou F, Lechevallier E, Baume D, Camerlo J, Cowen D, Coulange C, Serment G, Resbeut M, Maraninchi D.
    Eur Cytokine Netw; 1996 Sep 01; 7(3):395-9. PubMed ID: 8954183
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Neoadjuvant treatment of cancer of the bladder with M-VAC/M-VEC, and bladder-sparing policy: preliminary report of a non-randomized study.
    Galante E, Ferroni C, Bianchi S, Megale C, Molinaro S, Maymone S.
    J Exp Ther Oncol; 1996 Jul 01; 1(4):237-41. PubMed ID: 9414410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.